RxDoctor Payments Data

Serrina Yozsa, DPM

Podiatrist · Scottsdale, AZNPI 1720065113

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,833 and has fallen 89.8% since, to $186 in 2025. Among podiatrist clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,951in general payments, 2019–2025

Across 253 payments — averaging $23.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$1K
  • Paratek Pharmaceuticals, Inc.$773
  • Amgen$723
  • Smith+Nephew$472
  • DJO, LLC$348
  • Kerecis Limited$264
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$5,935100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,951 in reported general payments places this provider in the 90th percentile of 151 podiatrist providers in Arizona.

See all podiatrist providers in Arizona

Medicare billing

Part B allowed, 2024
$449,598
Medicare patients
310
Services billed
2,192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox19$1,085
Terbinafine Hcl41$653
CiclopiroxCiclopirox Olamine25$580
Mupirocin54$467
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$315
Doxycycline Hyclate20$201
Meloxicam36$109
Allopurinol12$4

Paid to pharmacies, not to this prescriber.

Other podiatrist in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →